| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3180149 | Actas Dermo-Sifiliográficas | 2014 | 7 Pages |
Abstract
Induction therapy with monoclonal and polyclonal antibodies in renal transplant recipients is not associated with an increased risk of NMSC. While mTOR inhibitors are associated with a lower risk of posttransplant NMSC, it remains to be determined whether a switch to these drugs is useful in the management of patients who develop multiple NMSCs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J. Bernat-GarcÃa, M. Morales Suárez-Varela, J.J. Vilata-Corell, A. Marquina-Vila, L. Pallardo, J. Crespo,